National Cancer Institute (NCI) - Company Record
National Cancer Institute (NCI)
National Cancer Institute (NCI)
- Bethesda, MD; part of National Institutes of Health (NIH)
Related product monographs:
Cancer vaccine, poxvirus vectors, rDNA
-- R&D ; Tech
CD20 Mab, rDNA/Y-90 & In-111 radioconj, rDNA
-- Tech.
EGF receptor Mab, chimeric, rDNA
-- R&D ; Former
Interleukin-13–Pseudomonas toxin, rDNA
-- R&D ; Tech
Interleukin-2 receptor Mab, rDNA/Roche
-- R&D ; Tech.
Keratinocyte growth factor, rDNA
-- R&D ; Tech.
Lyme Vaccine, rDNA/GSK
-- Tech.
p53 Gene Therapy, rDNA/Introgen
-- R&D ; Tech.
Prostate Cancer Vaccine, Poxvirus Vectors (rDNA)
-- R&D ; Tech.
CD3 Mab
-- R&D ; Tech.
Prostate Mab–In 111 radioconj.
-- Tech.
TAG-72 Mab, conc.
-- Tech. ; Former
TAG-72 Mab–In111 radioconj./Cytogen
-- Tech.
TAG-72 Mab–In111 radioconj./Neoprobe
-- R&D ; Tech. ; Former
Dendritic Cell Vaccine, Personalized/BiovaxID
-- R&D ; Tech.
Staphylococcus vaccine (rDNA)
-- R&D ; Tech.
Bcl-2 Antisense Drug
-- R&D ; Tech.
CMV Antisense Drug
-- R&D ; Tech.
Location
- Bethesda MD 20892 USA
              
Further information:
Description, ordering information, etc.
Order/Inquiry
Products Database
Copyright ©2020.
Biotechnology Information Institute